Biocidin Revenue and Competitors

Aptos, CA

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • Biocidin's estimated annual revenue is currently $10.8M per year.(i)
  • Biocidin's estimated revenue per employee is $245,455

Employee Data

  • Biocidin has 44 Employees.(i)
  • Biocidin grew their employee count by 7% last year.

Biocidin's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP MarketingReveal Email/Phone
3
Director Digital StrategyReveal Email/Phone
4
Director Events & Public RelationsReveal Email/Phone
5
Director Technology StrategyReveal Email/Phone
6
Senior Director MarketingReveal Email/Phone
7
Brand ManagerReveal Email/Phone
8
Product ManagerReveal Email/Phone
9
Regional Account ManagerReveal Email/Phone
10
Territory Account ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$14.3M5716%N/AN/A
#2
$179.6M435-1%N/AN/A
#3
$6.5M2812%N/AN/A
#4
$5.3M21-9%N/AN/A
#5
$12.4M5019%N/AN/A
#6
$13.6M460%N/AN/A
#7
$6.5M23-8%N/AN/A
#8
$18M7116%N/AN/A
#9
$10.2M472%N/AN/A
#10
$181.6M4767%N/AN/A
Add Company

What Is Biocidin?

Biocidin® is the flagship brand from a Bio-Botanical Research®, Inc., the recognized leader in the field of Botanical Supplements. Biocidin® was founded in response to the needs of physicians addressing the microbiome and systemic health and wellness. Our powerful formulations are clinically tested and evidence-based and have been a favorite amongst recognized healthcare practitioners for overall GI and Gut Health for the past 30 years. In response to a continued request for effective solutions to address problems associated with intestinal ecology, immune system dysregulation and detoxification, we created an end-to-end product portfolio that continues to lead the way in functional and integrative medicine.

keywords:N/A

N/A

Total Funding

44

Number of Employees

$10.8M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10M50-2%N/A
#2
$19.2M5510%N/A
#3
$3.5M5610%N/A
#4
$16.2M56-3%N/A
#5
N/A609%N/A